Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Sleep problems in advanced disease 

Andrew Davies
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.19-4-302
Clin Med July 2019
Andrew Davies
ARoyal Surrey County Hospital, Guildford, UK
Roles: consultant in palliative medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: adavies12@nhs.net
  • Article
  • Figures & Data
  • Info & Metrics
Loading

ABSTRACT

Sleep problems are relatively common in patients with advanced disease, and are associated with significant morbidity in these groups of patients. The focus of this article is sleep problems in patients with advanced cancer, and specifically insomnia, ‘vivid’ dreams and nightmares. However, other sleep problems are also relatively common in this group of patients, including sleep-related breathing disorders and circadian rhythm sleep-wake disorders. Healthcare professionals should screen all patients with advanced diseases for sleep problems and, equally, initiate appropriate (evidence-based) interventions when they are discovered.

KEYWORDS
  • Palliative care
  • insomnia
  • vivid dreams
  • nightmares
  • sleep disturbance

Key points

  • Sleep problems are common in patients with advanced disease.

  • Sleep problems are associated with significant morbidity in patients with advanced diseases.

  • Insomnia is often secondary to related physical symptoms (and psychological problems).

  • Management of insomnia primarily involves treatment of perpetuating factors, sleep hygiene measures, and non-pharmacological interventions (cognitive behavioural therapy).

Introduction

Sleep is a complex phenomenon, which serves various functions, and which is essential for existence.1 Sleep problems are common in patients with advanced cancer and in patients with other life limiting conditions.2 This article focuses on the literature in patients with advanced cancer, but much of the content equally applies to patients with other life limiting conditions.2

Sleep is a cyclical process (∼90 min per cycle), which consists of two types of sleep (rapid eye movement (REM) sleep and non-REM sleep) and five stages of sleep (stages 1–4 = non-REM sleep, stage 5 = REM sleep).1,2 The different types/stages of sleep are characterised by distinctive electroencephalogram (EEG) features, and distinctive physical features. For example, REM/stage 5 sleep is characterised by marked EEG activity, muscle hypotonia (on electromyography), fast horizontal eye movements (on electro-oculography) and variability in vital signs.

The American Academy of Sleep Medicine / International Classification of Sleep Disorders categorise sleep disorders into six clinical divisions: insomnia, sleep-related breathing disorders, central disorders of hypersomnolence, circadian rhythm sleep-wake disorders, parasomnias and sleep-related movement disorders.3

This article focusses on the common symptoms reported by patients with advanced cancer. However, other sleep problems also appear to be common in this group of patients.2 For example, opioid analgesics (which are often prescribed in patients with advanced cancer) are associated with sleep-related breathing disorders, including central sleep apnoea, obstructive sleep apnoea and ataxic or irregular breathing patterns.4 Moreover, these sleep-related breathing disorders are linked not only to increased morbidity (eg daytime sleepiness, cognitive impairment) but also to increased mortality.

Insomnia

Insomnia has been defined as ‘a persistent difficulty with sleep initiation, duration, consolidation, or quality that occurs despite adequate opportunity and circumstances for sleep, and results in some form of daytime impairment’.3 Patients with advanced cancer often report ‘insomnia’, and many meet the diagnostic criteria for short-term insomnia disorder (Box 1), or even chronic insomnia disorder (ie the sleep disturbance and associated daytime symptoms have been present for at least 3 months, and the sleep disturbance and associated daytime symptoms occur at least three times per week).3 However, the prevalence of these sleep disorders is unknown in this group of patients. Nevertheless, researchers have reported that 62–70% patients with advanced cancer had poor sleep quality as assessed by the Pittsburgh Sleep Quality Index.5,6

View this table:
  • View inline
  • View popup
Box 1.

Diagnostic criteria for short-term insomnia disorder. Adapted from Zucconi M, Ferri R. Classification of sleep disorders. In: Bassetti CL, Dogan Z, Peigneux P (eds). Sleep Medicine Textbook. Regensburg: European Sleep Research Society, 2014.

Davies et al reported that in their study of 174 patients with advanced cancer, 30% patients had trouble sleeping because they couldn't get to sleep within 30 minutes three or more times a week during the previous month, and that 60% patients had trouble sleeping because they woke in the middle of the night or early morning three or more times a week in the previous month.5 It should be noted that the quality of sleep is not always related to the duration of sleep,7 and that it is often worse among inpatients (as compared to outpatients),5,8 and often poor among carers (cf general population).7,9 Indeed, the prevalence of insomnia in carers is not dissimilar to that in patients with advanced cancer.9

In most cases, the insomnia develops following the diagnosis,10,11 and it may be precipitated by the cancer per se, the cancer treatment and/or concomitant physical symptoms and psychological problems.11 Furthermore, it may be perpetuated by similar factors, as well as by environmental factors, maladaptive thinking (relating to sleep) and maladaptive behaviours (relating to ‘sleep hygiene’).11 Hugel et al reported that in their study of 73 patients with advanced cancer, 60% patients related their insomnia to uncontrolled physical symptoms (predominantly pain and urinary frequency).10

Insomnia may be associated with daytime sleepiness, cognitive impairment, accidents/injuries, anxiety,12 depression,12 delirium,13 fatigue and, unsurprisingly, impaired quality of life.14 Insomnia is associated with suppression of the immune system, which may have implications in terms of development of infections, and also progression of cancers. Indeed, insomnia has been shown to be associated with a decreased response to chemotherapy, and with a decreased (overall) survival, in an observational study of 361 patients with metastatic colorectal cancer.15

The management of insomnia includes treatment of perpetuating factors (eg physical symptoms, psychological problems), sleep hygiene measures (Box 2), non-pharmacological interventions (eg cognitive behavioural therapy, exercise), pharmacological interventions and combination of modalities.16 Pharmacological interventions should be used with care, restricted to patients with related distress and prescribed for only short periods (and intermittently rather than continuously; Box 3).17 The choice of hypnotic depends on a variety of factors, including the clinical features of the insomnia.17

View this table:
  • View inline
  • View popup
Box 2.

Sleep hygiene measures. Adapted from Howell D, Oliver TK, Keller-Olaman S et al. A pan-Canadian practice guideline: Prevention, screening, assessment and treatment of sleep disturbances in adults with cancer. Toronto: Canadian Partnership Against Cancer (Cancer Journey Advisory Group) and the Canadian Association of Psychosocial Oncology, 2012.

View this table:
  • View inline
  • View popup
Box 3.

Recommendations on use of pharmacological interventions for sleep disturbance.14,15

Vivid dreams

Vivid dreams (defined as ‘unusually clear, long dreams with elaborate scenarios and possibly strong emotions, that occurred only when sleeping and were acutely remembered’) appear to be common in patients with advanced cancer (34.5% in the previous month).5 Other investigators have reported an even higher prevalence in this population.7 Vivid dreams are associated with sleep disturbance,5 which increases the risk of waking up during REM sleep (which is the sleep stage primarily associated with dreaming). Vivid dreams are also associated with a higher psychological symptom burden,5 which itself is associated with sleep disturbance.11 However, vivid dreams do not appear to be more common with worse performance status (a surrogate for worse prognosis), and were not associated with the use of opioid analgesics in an observational study of 174 patients with advanced cancer.5

Patients reporting vivid dreams should be assessed for underlying sleep disturbance and/or psychological problems, and these should be appropriately managed (the management of sleep disturbance is discussed in the previous section). Specific treatment is invariably not required, although patients may require reassurance about the significance of the vivid dreams.

Nightmares

Nightmares appear to be common in patients with advanced cancer (18% in the previous month),5 although not necessarily more common than in the general population.18 Nightmares are associated with sleep disturbance in the general population,19 and in patients with advanced cancer,5 and it has been suggested that the sleep disturbance precipitates (recall of) the nightmares, rather than the nightmares precipitating the sleep disturbance.20 Nightmares are associated higher physical and psychological burden,5 which themselves are associated with sleep disturbance.11 However, nightmares do not appear to be associated with the use of opioid analgesics in two observational studies of 297 patients with advanced cancer (or a review of opioid adverse effects),5,21,22 although there are a number of other drugs that can precipitate nightmares (eg sedatives/hypnotics, beta blockers, amphetamines, dopamine agonists).

Patients reporting nightmares should be assessed for underlying sleep disturbance and/or physical and psychological problems, and these should be appropriately managed. Specific treatment is generally not required, but in those cases that meet the diagnostic criteria for ‘nightmare disorder’ (ie related/specific sleep disorder), recommended treatments include specific behavioural and psychological interventions (eg image rehearsal therapy, cognitive behavioural therapy), and specific pharmacological interventions (eg nitrazepam, prazosin).23

Conclusion

Sleep disorders are common in patients with advanced disease, and are associated with significant morbidity in these groups of patients. Healthcare professionals should routinely screen for sleep disorders in patients with advanced disease, since many are amenable to simple interventions (with a resultant improvement in health-related quality of life).

  • © Royal College of Physicians 2019. All rights reserved.

References

  1. ↵
    1. American Sleep Association
    , 2019. www.sleepassociation.org [Accessed 14 April 2019].
  2. ↵
    1. Mystakidou K
    , Panagiotou I, Parpa E, Tsilika E. Sleep disorders. In: Cherny NI, Fallon MT, Kaasa S, Portenoy RK, Currow DC (eds). Oxford Textbook of Palliative Medicine, 5th edn. Oxford: Oxford University Press, 2015.
  3. ↵
    1. Zucconi M
    , Ferri R. Classification of sleep disorders. In: Bassetti CL, Dogan Z, Peigneux P (eds). Sleep Medicine Textbook. Regensburg: European Sleep Research Society, 2014.
  4. ↵
    1. Cheatle MD
    , Webster LR. Opioid therapy and sleep disorders: risks and mitigation strategies. Pain Med 2015;16:522–6.
    OpenUrl
  5. ↵
    1. Davies AN
    , Patel SD, Gregory A, Lee B. Observational study of sleep disturbance in advanced cancer. BMJ Support Palliat Care 2017;7:435–40.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Yennurajalingam S
    , Balachandran D, Pedraza Cardozo SL, et al. Patient-reported sleep disturbance in advanced cancer: frequency, predictors and screening performance of the Edmonton Symptom Assessment System sleep item. BMJ Support Palliat Care 2017;7:274–80.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Gibbins J
    , McCoubrie R, Kendrick AH, et al. Sleep-wake disturbances in patients with advanced cancer and their family carers. J Pain Symptom Manage 2009;38:860–70.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Dobing S
    , Frolova N, McAlister F, Ringrose J. Sleep quality and factors influencing self-reported sleep duration and quality in the general internal medicine inpatient population. PLoS One 2016;11:e0156735.
    OpenUrl
  9. ↵
    1. Maltby KF
    , Sanderson CR, Lobb EA. Phillips JL. Sleep disturbances in caregivers of patients with advanced cancer: a systematic review. Palliat Support Care 2017;15:125–40.
    OpenUrl
  10. ↵
    1. Hugel H
    , Ellershaw JE, Cook L, et al. The prevalence, key causes and management of insomnia in palliative care patients. J Pain Symptom Manage 2004;27:316–21.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Graci G.
    Pathogenesis and management of cancer-related insomnia. J Support Oncol 2005;3:349–59.
    OpenUrlPubMed
  12. ↵
    1. Dong ST
    , Butow PN, Costa DS, Lovell MR. Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manage 2014;48:411–50.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Slatore CG
    , Goy ER, O'Hearn DJ, et al. Sleep quality and its association with delirium among veterans enrolled in hospice. Am J Geriatr Psychiatry 2012;20:317–26.
    OpenUrlPubMed
  14. ↵
    1. Lis CG
    , Gupta D, Grutsch JF. The relationship between insomnia and patient satisfaction with quality of life in cancer. Support Care Cancer 2008;16:261–6.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Innominato PF
    , Spiegel D, Ulusakarya A, et al. Subjective sleep and overall survival in chemotherapy-naive patients with metastatic colorectal cancer. Sleep Med 2015;16:391–8.
    OpenUrl
  16. ↵
    1. Howell D
    , Oliver TK, Keller-Olaman S, et al. A pan-Canadian practice guideline: Prevention, screening, assessment and treatment of sleep disturbances in adults with cancer. Toronto: Canadian Partnership Against Cancer (Cancer Journey Advisory Group) and the Canadian Association of Psychosocial Oncology, 2012.
  17. ↵
    1. British National Formulary
    , 2019. https://bnf.nice.org.uk [Accessed 15 February 2019].
  18. ↵
    1. Bjorvatn B
    , Gronli J, Pallesen S. Prevalence of different parasomnias in the general population. Sleep Medicine 2010;11:1031–4.
    OpenUrlPubMed
  19. ↵
    1. Schredl M.
    Characteristics and contents of dreams. Int Rev Neurobiol 2010;92:135–54.
    OpenUrlPubMed
  20. ↵
    1. Simor P
    , Horvath K, Gombos F, Takacs KP, Bodizs R. Disturbed dreaming and sleep quality: altered sleep architecture in subjects with frequent nightmares. Eur Arch Psychiatry Clin Neurosci 2012;262:687–96.
    OpenUrlPubMed
  21. ↵
    1. Mercadante S
    , Girelli D, Casuccio A. Sleep disorders in advanced cancer patients: prevalence and factors associated. Support Care Cancer 2004;12:355–9.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Vella-Brincat J
    , Macleod AD. Adverse effects of opioids on the central nervous systems of palliative care patients. J Pain Palliat Care Pharmacother 2007;21:15–25.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Morgenthaler TI
    , Auerbach S, Casey KR, et al. Position paper for the treatment of nightmare disorder in adults: an American Academy of Sleep Medicine position paper. J Clin Sleep Med 2018;14:1041–55.
    OpenUrl
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Sleep problems in advanced disease 
Andrew Davies
Clinical Medicine Jul 2019, 19 (4) 302-305; DOI: 10.7861/clinmedicine.19-4-302

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Sleep problems in advanced disease 
Andrew Davies
Clinical Medicine Jul 2019, 19 (4) 302-305; DOI: 10.7861/clinmedicine.19-4-302
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Key points
    • Introduction
    • Insomnia
    • Vivid dreams
    • Nightmares
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Nudge nudge, wink wink
  • Google Scholar

More in this TOC Section

  • CME Palliative Medicine (126358): self-assessment questionnaire
  • Venous thromboembolism and palliative care
  • Deprescribing in palliative care
Show more CME: Palliative medicine

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians